DNA Hypomethylation Affects Cancer-Related Biological Functions and Genes Relevant in Neuroblastoma Pathogenesis

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Mayol, Gemma ^a   Martín Subero, José I ^b   Ríos, José ^c,d   Queiros, Ana ^b   Kulis, Marta ^d   Suñol, Mariona ^a   Esteller, Manel ^b,e,f   Gómez, Soledad ^a   Garcia, Idoia ^a   de Torres, Carmen ^a   Rodríguez, Eva ^a   Galván, Patricia ^a   Mora, Jaume ^a   Lavarino, Cinzia ^a  

^a HOSPITAL SANT JOAN DE DÉU   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^d HOSPITAL CLÍNIC   (Spain)

^e BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

^f INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CYCLIN D1; DNA; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 6; OCTAMER TRANSCRIPTION FACTOR 2; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A;

3' UNTRANSLATED REGION; ARTICLE; BTC GENE; CARCINOGENESIS; CCND1 GENE; CELL MATURATION; CELL PROLIFERATION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DNA METHYLATION; EGF GENE; EPIGENETICS; FETUS; FGF6 GENE; GENE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE TARGETING; GENETIC ASSOCIATION; HOXD3 GENE; HUMAN; HUMAN TISSUE; MOLECULAR PATHOLOGY; NEUROBLASTOMA; NEUROPATHOLOGY; NUCLEOTIDE SEQUENCE; POU2F2 GENE; PRESCHOOL CHILD; PROMOTER REGION; PYROSEQUENCING; RASSF1A GENE; SPRR3 GENE;

CHILD; CHILD, PRESCHOOL; CYCLIN D1; DNA METHYLATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, NEOPLASM; HUMANS; INFANT; INFANT, NEWBORN; NEUROBLASTOMA; REPRODUCIBILITY OF RESULTS; SEQUENCE ANALYSIS, DNA; TEMPERATURE;

EID: 84868687137     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0048401     Document Type: Article

References (48)

1. Maris JM, Hogarty MD, Bagatell R, Cohn SL, (2007) Neuroblastoma. Lancet 369: 2106-2120.
2. Esteller M, (2008) Epigenetics in Cancer. N Engl J Med 358: 1148-1159.
3. Baylin SB, Jones PA, (2011) A decade of exploring the cancer epigenome - biological and translational implications. Nat Rev Cancer 11: 726-734.
4. Alaminos M, Davalos V, Cheung NK, Gerald WL, Esteller M, (2004) Clustering of gene hypermethylation associated with clinical risk groups in neuroblastoma. J Natl Cancer Inst 96: 1208-1219.
5. Michalowski MB, de Fraipont F, Plantaz D, Michelland S, Combaret V, et al. (2008) Methylation of tumor-suppressor genes in neuroblastoma: The RASSF1A gene is almost always methylated in primary tumors. Pediatr Blood Cancer 50: 29-32.
6. Kamimatsuse A, Matsuura K, Moriya S, Fukuba I, Yamaoka H, et al. (2009) Detection of CpG island hypermethylation of caspase-8 in neuroblastoma using an oligonucleotide array. Pediatr Blood Cancer 52: 777-783.
7. Carén H, Djos A, Nethander M, Sjöberg RM, Kogner P, et al. (2011) Identification of epigenetically regulated genes that predict patient outcome in neuroblastoma. BMC Cancer 11: 11-66.
8. Grau E, Martinez F, Orellana C, Canete A, Yañez Y, et al. (2011) Hypermethylation of apoptotic genes as independent prognostic factor in neuroblastoma disease. Mol Carcinog 50: 153-162.
9. Buckley PG, Das S, Bryan K, Watters KM, Alcock L, et al. (2011) Genome-wide DNA methylation analysis of neuroblastic tumors reveals clinically relevant epigenetic events and large-scale epigenomic alterations localized to telomeric regions. Int J Cancer 128: 2296-2305.
10. Molenaar JJ, van Sluis P, Boon K, Versteeg R, Caron HN, (2003) Rearrangements and increased expression of cyclin D1 (CCND1) in neuroblastoma. Genes Chromosomes & Cancer 36: 242-249.
11. Brodeur GM, Pritchard J, Berthold F, Carlsen NL, Castel V, et al. (1993) Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol 11: 1466-1477.
12. Bibikova M, Le J, Barnes B, Saedinia-Melnyk S, Zhou L, et al. (2009) Genome-wide DNA methylation profiling using Infinium® assay. Epigenomics 1: 177-200.
13. Kanduri M, Cahill N, Göransson H, Enström C, Ryan F, et al. (2010) Differential genome-wide array-based methylation profiles in prognostic subsets of chronic lymphocytic leukemia. Blood 115: 296-305.
14. Martín-Subero JI, Kreuz M, Bibikova M, Bentink S, Ammerpohl O, et al. (2009) New insights into the biology and origin of mature aggressive B-cell lymphomas by combined epigenomic, genomic, and transcriptional profiling. Blood 113: 2488-2497.
15. Martinez R, Martin-Subero JI, Rohde V, Kirsch M, Alaminos M, et al. (2009) A microarray-based DNA methylation study of glioblastoma multiforme. Epigenetics 4: 255-264.
16. Richter J, Ammerpohl O, Martín-Subero JI, Montesinos-Rongen M, Bibikova M, et al. (2009) Array-based DNA methylation profiling of primary lymphomas of the central nervous system. BMC Cancer 9: 455.
17. Martin-Subero JI, Ammerpohl O, Bibikova M, Wickham-Garcia E, Agirre X, et al. (2009) A comprehensive microarray-based DNA methylation study of 367 hematological neoplasms. PLoS One 4: e6986.
18. Westfall PH and Young SS (1993) Resampling-based Multiple Testing: Examples and Methods for p-values Adjustment. New York: John Wiley & Sons Inc.
19. Benjamini Y, Hochberg Y, (1995) Controlling the False Discovery Rate: a Practical and Powerful Approach to Multiple Testing. J R Stat Soc Series B Stat Methodol 57: 289-300.
20. Tost J, Gut I, (2007) DNA methylation analysis by Pyrosequencing. Nat Protoc 2: 2265-2275.
21. Wang Q, Diskin S, Rappaport E, Attiyeh E, Mosse Y, et al. (2006) Integrative genomics identifies distinct molecular classes of neuroblastoma and shows that multiple genes are targeted by regional alterations in DNA copy number. Cancer Res 66: 6050-6062.
22. Lavarino C, Garcia I, Mackintosh C, Cheung NK, Domenech G, et al. (2008) Differential expression of genes mapping to recurrently abnormal chromosomal regions characterize neuroblastic tumours with distinct ploidy status. BMC Med Genomics 1: 36.
23. Lavarino C, Cheung NK, Garcia I, Domenech G, de Torres C, et al. (2009) Specific gene expression profiles and chromosomal abnormalities are associated with infant disseminated neuroblastoma. BMC Cancer 9: 44.
24. Dennis G Jr, Sherman BT, Hosack DA, Yang J, Gao W, et al. (2003) DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 4: P3.
25. Hesson LB, Cooper WN, Latif F, (2007) The role of RASSF1A methylation in cancer. Dis Markers 23: 73-87.
26. Kron K, Pethe V, Briollais L, Sadikovic B, Ozcelik H, et al. (2009) Discovery of novel hypermethylated genes in prostate cancer using genomic CpG island microarrays. PLoS One 4: e4830.
27. Liu L, Kron KJ, Pethe W, Demetrashvili N, Nesbitt ME, et al. (2011) Association of tissue promoter methylation levels of APC, TGFβ2, HOXD3 and RASSF1A with prostate cancer progression. Int J Cancer 129: 2454-2462.
28. van Noesel MM, Versteeg R, (2004) Pediatric neuroblastomas: genetic and epigenetic 'danse macabre'. Gene 325: 1-15.
29. Stefanska B, Huang J, Bhattacharyya B, Suderman M, Hallett M, et al. (2011) Definition of the landscape of promoter DNA hypomethylation in liver cancer. Cancer Res 71: 5891-5903.
30. Calvanese V, Fernández AF, Urdinguio RG, Suárez-Alvarez B, Mangas C, et al. (2012) A promoter DNA demethylation landscape of human hematopoietic differentiation. Nucleic Acids Res 40: 116-131.
31. Molenaar JJ, Ebus ME, Koster J, van Sluis P, van Noesel CJ, et al. (2008) Cyclin D1 and CDK4 activity contribute to the undifferentiated phenotype in neuroblastoma. Cancer Res 68: 2599-2609.
32. Sano H, Bonadio J, Gerbing RB, London WB, Matthay KK, et al. (2006) International neuroblastoma pathology classification adds independent prognostic information beyond the prognostic contribution of age. Eur J Cancer 42: 1113-1119.
33. Shimada H, Ambros IM, Dehner LP, Hata J, Joshi VV, et al. (1999) The International Neuroblastoma Pathology Classification (the Shimada system). Cancer 86: 364-372.
34. Donnellan R, Chetty R, (1998) Cyclin D1 and human neoplasia. Mol Pathol 51: 1-7.
35. Molenaar JJ, Ebus ME, Koster J, Santo E, Geerts D, et al. (2010) Cyclin D1 is a direct transcriptional target of GATA3 in neuroblastoma tumor cells. Oncogene 29: 2739-2745.
36. Deshpande A, Pastore A, Deshpande AJ, Zimmermann Y, Hutter G, et al. (2009) 3′UTR mediated regulation of the cyclin D1 proto-oncogene. Cell Cycle 8: 3584-3592.
37. Shivakumar L, Minna J, Sakamaki T, Pestell R, White MA, (2002) The RASSF1A tumor suppressor blocks cell cycle progression and inhibits cyclin D1 accumulation. Mol Cell Biol 22: 4309-4318.
38. Pizzi S, Azzoni C, Bottarelli L, Campanini N, D'Adda T, et al. (2005) RASSF1A promoter methylation and 3p21.3 loss of heterozygosity are features of foregut, but not midgut and hindgut, malignant endocrine tumors. J Pathol 206: 409-416.
39. Ammerpohl O, Pratschke J, Schafmayer C, Haake A, Faber W, et al. (2012) Distinct DNA methylation patterns in cirrhotic liver and hepatocellular carcinoma. Int J Cancer 130: 1319-1328.
40. Kim JC, Yu JH, Cho YK, Jung CS, Ahn SH, et al. (2011) Expression of SPRR3 is associated with tumor cell proliferation in less advanced stages of breast cancer. Breast Cancer Res Treat 133: 909-916.
41. Cho DH, Jo YK, Roh SA, Na YS, Kim TW, et al. (2010) Upregulation of SPRR3 promotes colorectal tumorigenesis. Mol Med 16: 271-277.
42. Gómez-Gaviro MV, Scott CE, Sesay AK, Matheu A, Booth S, et al. (2012) Betacellulin promotes cell proliferation in the neural stem cell niche and stimulates neurogenesis. Proc Natl Acad Sci USA 109: 1317-1322.
43. Chen G, Gulbranson DR, Yu P, Hou Z, Thomson JA, (2012) Thermal stability of fibroblast growth factor protein is a determinant factor in regulating self-renewal, differentiation, and reprogramming in human pluripotent stem cells. Stem Cells 30: 623-630.
44. Theodorou E, Dalembert G, Heffelfinger C, White E, Weissman S, et al. (2009) A high throughput embryonic stem cell screen identifies Oct-2 as bifunctional regulator of neuronal differentiation. Genes Dev 23: 575-588.
45. Taniguchi Y, Tanaka O, Sekiguchi M, Takekoshi S, Tsukamoto H, et al. (2011) Enforced expression of the transcription factor HOXD3 under the control of the Wnt1 regulatory element modulates cell adhesion properties in the developing mouse neural tube. J Anat 219: 589-600.
46. Botti E, Spallone G, Moretti F, Marinari B, Pinetti V, et al. (2011) Developmental factor IRF6 exhibits tumor suppressor activity in squamous cell carcinoma. Proc Natl Acad Sci USA 108: 13710-13715.
47. Wulf P, Suter U, (1999) Embryonic expression of epithelial membrane protein 1 in early neurons. Brain Res Dev Brain Res 116: 169-180.
48. Zhang J, Cao W, Xu Q, Chen WT, (2011) The expression of EMP1 is downregulated in oral squamous cell carcinoma and possibly associated with tumor metastasis. J Clin Pathol 64: 25-29.